Mon, Jan 26, 2015, 9:46 AM EST - U.S. Markets close in 6 hrs 14 mins


% | $
Quotes you view appear here for quick access.

Omeros Corporation (OMER) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • tredleon tredleon Jan 15, 2013 7:28 PM Flag

    Why should I buy OMER now?

    You first talk of oral/IV drugs that are available to provide mydriasis and then speak to generic drops - which is it? Anybody that has had an eye exam knows there are drops that are used to dialate the pupil - similar drops are used prior to surgery and the OMS302 irrigation drug is used to maintain the dialation during surgery - that is the comparison in the trial - how dialation changes with and without the use of OMS302 during surgery. Obviously, once the surgery has begun it is apparently not kosher to use additional drops, or that would be done and OMS302 would have no purpose. I find it fascinating that people believe a company would waste millions of dollars on developing a drug and pushing it through the clinic where there is no apparent need? I'm not saying OMS302 is a blockbuster indication, but the idea that there is no market for this drug because the need is already being met with drugs currently in use seems awfully simplistic - again, why would Wedbush put the market potential at $600M if there generic alternatives already being utilized as effectively. Also, any time doctors can generate a medical result without having to use a systemic drug, they will opt for it - avoiding potential side effects and problems with oral/IV drugs has tremendous value, especially when dealing with senior patients, who typically are on numerous prescriptions, already, presenting systemic interaction risks. When it comes to the knee surgery drug, the benefit is reducing the use of systemic anti-inflammatories and pain killers post-surgery, which is something doctors are clearly in favor of, so to say that there is no utility in OMS103HP is, again, simplistic.

22.7201-0.1399(-0.61%)9:45 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.